Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Bladder Cancer

  Free Subscription


2 Anticancer Res
5 Bladder Cancer
1 Cancer Treat Rev
1 Cell Death Dis
1 Cell Mol Biol (Noisy-le-grand)
1 Clin Genitourin Cancer
1 Food Funct
1 Gan To Kagaku Ryoho
1 Ind Health
1 Indian J Clin Biochem
2 J Clin Oncol
1 J Obstet Gynaecol
1 J Proteomics
1 JAMA Oncol
1 Lakartidningen
1 Medicine (Baltimore)
1 Mol Med Rep
1 PLoS One
1 Sci Rep
1 Urol Int
1 Urol Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Anticancer Res

  1. HANCOCK BM, McGuire KL, Tsuji S, Reil K, et al
    A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival.
    Anticancer Res. 2016;36:6243-6248.
    PubMed     Text format     Abstract available

  2. MANIG L, Kasmann L, Janssen S, Rades D, et al
    Predicting Survival After Irradiation of Metastases from Transitional Carcinoma of the Bladder.
    Anticancer Res. 2016;36:6663-6665.
    PubMed     Text format     Abstract available

    Bladder Cancer

  3. ZARGAR H, Almassi N, Kovac E, Ercole C, et al
    Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:57-63.
    PubMed     Text format     Abstract available

  4. MATULEWICZ RS, DeLancey JO, Pavey E, Schaeffer EM, et al
    Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer.
    Bladder Cancer. 2017;3:45-49.
    PubMed     Text format     Abstract available

  5. VON RUNDSTEDT FC, Mata DA, Kryvenko ON, Shah AA, et al
    Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study.
    Bladder Cancer. 2017;3:35-44.
    PubMed     Text format     Abstract available

  6. BAUMANN BC, Sargos P, Eapen LJ, Efstathiou JA, et al
    The Rationale for Post-Operative Radiation in Localized Bladder Cancer.
    Bladder Cancer. 2017;3:19-30.
    PubMed     Text format     Abstract available

  7. FRANTZI M, Vlahou A
    Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions.
    Bladder Cancer. 2017;3:1-18.
    PubMed     Text format     Abstract available

    Cancer Treat Rev

  8. BUTTIGLIERO C, Tucci M, Vignani F, Scagliotti GV, et al
    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
    Cancer Treat Rev. 2017;54:1-9.
    PubMed     Text format     Abstract available

    Cell Death Dis

  9. YE W, Chen C, Gao Y, Zheng ZS, et al
    Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.
    Cell Death Dis. 2017;8:e2581.
    PubMed     Text format     Abstract available

    Cell Mol Biol (Noisy-le-grand)

  10. HADAMI K, Ameziane El Hassani R, Ameur A, Dakka N, et al
    Association between GPX1 Pro189Leu polymorphism and the occurrence of bladder cancer in Morocco.
    Cell Mol Biol (Noisy-le-grand). 2016;62:38-43.
    PubMed     Text format     Abstract available

    Clin Genitourin Cancer

  11. WILDE L, Ali SM, Solomides CC, Ross JS, et al
    Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2016 Dec 22. pii: S1558-7673(16)30358.
    PubMed     Text format    

    Food Funct

  12. WU Y, Zhang X, Li Z, Yan H, et al
    Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.
    Food Funct. 2017 Jan 31. doi: 10.1039/c6fo01535.
    PubMed     Text format     Abstract available

    Gan To Kagaku Ryoho

  13. ASAI K, Murata M, Saso K, Yamada M, et al
    [A Case of Metachronous Liver Metastases of Gall Bladder Cancer Successfully Treated by Liver Resection].
    Gan To Kagaku Ryoho. 2016;43:2092-2094.
    PubMed     Text format     Abstract available

    Ind Health

  14. OGAWA Y
    Chemical poisonings, new and old.
    Ind Health. 2016;54:99-100.
    PubMed     Text format    

    Indian J Clin Biochem

  15. VERMA A, Kapoor R, Mittal RD
    Cluster of Differentiation 44 (CD44) Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.
    Indian J Clin Biochem. 2017;32:74-83.
    PubMed     Text format     Abstract available

    J Clin Oncol

  16. KUSHI LH, Quinn VP, Ghai NR, Roh JM, et al
    Identifying lifestyle and genetic factors to prevent recurrence of non-muscle invasive bladder cancer in a prospective cohort study at Kaiser Permanente (the Be-Well study).
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  17. DANFORTH KN, Kwan ML, Bulkley JE, O'Keeffe-Rosetti MC, et al
    Recovery challenges faced by bladder cancer survivors after recent cystectomy and urinary diversion.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

    J Obstet Gynaecol

  18. ALLEEMUDDER DI, Alleemudder AI, Harry D, Fountain S, et al
    Bladder squamous cell carcinoma in pregnancy.
    J Obstet Gynaecol. 2016;36:388-9.
    PubMed     Text format    

    J Proteomics

  19. ABBAOUI B, Telu KH, Lucas CR, Thomas-Ahner JM, et al
    The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
    J Proteomics. 2017 Jan 26. pii: S1874-3919(17)30026.
    PubMed     Text format     Abstract available

    JAMA Oncol

  20. LIU D, Plimack ER, Hoffman-Censits J, Garraway LA, et al
    Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.
    JAMA Oncol. 2016;2:1094-6.
    PubMed     Text format    


  21. LIEDBERG F, Hoglund M
    [Not Available].
    Lakartidningen. 2016;113.
    PubMed     Text format    

    Medicine (Baltimore)

  22. LI J, Wang P, Wang B
    Unique Case Report of Pineal Gland Metastasis From Bladder Carcinoma.
    Medicine (Baltimore). 2016;95:e3622.
    PubMed     Text format     Abstract available

    Mol Med Rep

  23. TAO S, Meng S, Zheng X, Xie L, et al
    ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer.
    Mol Med Rep. 2017 Jan 24. doi: 10.3892/mmr.2017.6141.
    PubMed     Text format     Abstract available

    PLoS One

  24. MATSUO T, Miyata Y, Asai A, Sagara Y, et al
    Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer.
    PLoS One. 2017;12:e0171091.
    PubMed     Text format     Abstract available

    Sci Rep

  25. CUI X, Shen D, Kong C, Zhang Z, et al
    NF-kappaB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
    Sci Rep. 2017;7:40723.
    PubMed     Text format     Abstract available

    Urol Int

  26. MOSCHINI M, Shariat SF, Freschi M, Soria F, et al
    Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2017 Feb 1. doi: 10.1159/000454736.
    PubMed     Text format     Abstract available

    Urol Oncol

  27. LEE D, Yoo S, You D, Hong B, et al
    Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Urol Oncol. 2017 Jan 27. pii: S1078-1439(16)30366.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.